Toric IOLs reduce astigmatism more than PCRIs

Article

Both toric IOLs and peripheral corneal relaxing incisions (PCRIs) reduce astigmatism, but toric IOLs do so to a greater extent as well as being more predictable, according to results of a recently published study.

Both toric IOLs and peripheral corneal relaxing incisions (PCRIs) reduce astigmatism, but toric IOLs do so to a greater extent as well as being more predictable, according to results of a study recently published in the Journal of Cataract & Refractive Surgery.

For this prospective masked bilateral randomized study, researchers from Moorfields Eye Hospital NHS Foundation Trust, London, enrolled 30 patients (60 eyes) with a preoperative corneal astigmatism of 1.0 to 2.5 D. All patients received a toric IOL in one eye and nontoric IOL plus PCRI in the other eye. Postoperative follow-up was done at 1 hour, 1 month and 6 months to measure uncorrected distance visual acuity, corrected distance visual acuity, autorefraction and subjective refraction. The IOL axis was assessed with retroillumination photos.

Researchers found a statistically significant difference in the mean astigmatism vector reduction in the toric IOL group compared with the PCRI group (1.74 D vs 1.27 D, respectively; P = 0.042). Mean absolute rotation of the toric IOL was 2.5 degrees (maximum 6.3 degrees) in the first 6 months postoperatively. Astigmatism increased in the PCRI group between the 1-month and the 6-month follow-up (mean: 0.38 D; maximum: 1.00 D; P

To view the abstract of this study, click here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
© 2025 MJH Life Sciences

All rights reserved.